{"id":537839,"date":"2010-04-21T14:24:49","date_gmt":"2010-04-21T18:24:49","guid":{"rendered":"http:\/\/www.technologytransfertactics.com\/content\/?p=6371"},"modified":"2010-04-21T14:24:49","modified_gmt":"2010-04-21T18:24:49","slug":"series-of-royalty-rate-references-expands-to-five-titles","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/537839","title":{"rendered":"Series of royalty rate references expands to five titles"},"content":{"rendered":"<p>A popular series of royalty rate benchmarking references has been                expanded to five titles with the addition of two market-specific                editions focused on medical devices and computer and communications                technologies, respectively. Authored by respected royalty rate and                valuation expert Russell Parr &#8212; who has spent more than two decades                gathering deal terms &#8212; each of the five editions goes beyond raw                rates and data and puts each transaction in context, including descriptions                of the licensed technologies, full compensation terms, identity                of the licensor and licensee, transaction background and history,                and market analysis and benefits of the licensed technology. The                two newest editions are designed to allow for less expensive access                for those with specific interest in those technology spaces. The                five titles are:<\/p>\n<ul>\n<li> Royalty Rates for Technology, 4th Edition<\/li>\n<li> Royalty Rates for Pharmaceuticals and Biotechnology, 6th Edition<\/li>\n<li> Royalty Rates for Technology: Medical Devices and Diagnostics                  Edition<\/li>\n<li> Royalty Rates for Technology: Computer and Communications Edition<\/li>\n<li> Royalty Rates for Trademarks and Copyrights, 4th Edition<\/li>\n<\/ul>\n<p><a href=\"http:\/\/www.technologytransfertactics.com\/content\/ipra-en\/\">CLICK                HERE for complete details. <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A popular series of royalty rate benchmarking references has been expanded to five titles with the addition of two market-specific editions focused on medical devices and computer and communications technologies, respectively. Authored by respected royalty rate and valuation expert Russell Parr &#8212; who has spent more than two decades gathering deal terms &#8212; each of [&hellip;]<\/p>\n","protected":false},"author":67,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-537839","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/537839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/67"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=537839"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/537839\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=537839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=537839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=537839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}